Cell Metabolism | 非酒精性脂肪性肝病的新机制 (上海交通大学)

文摘   2024-09-16 20:33   上海  

Paper Reading

01

Amelioration of nonalcoholic fatty liver disease by inhibiting the deubiquitylating enzyme RPN11


Bing Zhou, et al.
Cell Metabolism, 2024

    NAFLD/NASH emerged as the most rapidly ascending etiology of liver cancer globally over the past decade. Yet, to date, only one pharmaceutical, the TRb agonist Resmetirom, has been greenlit for market release, with a modest patient response rate of 25-30% and a prohibitive cost, averaging $40,000-$50,000 annually. Consequently, there is an imperative to further elucidate the pathogenic mechanisms of NAFLD/NASH to uncover novel therapeutic targets and strategies. Zhou’s research, leveraging a spectrum of NAFLD/NASH animal models—including mice on high-fat diets, those subjected to diets rich in fat, cholesterol, and fructose, and those on choline-deficient high-fat regimens—unveiled that the deubiquitinating enzyme RPN11 augments the stability and abundance of the RNA methyltransferase METTL3 by dismantling its ubiquitin marks. This enhancement subsequently boosts the expression of the acyltransferase ACSS3 and histone propionylation, upregulating the key lipogenic enzyme FASN and promoting the de novo synthesis of lipids, culminating in hepatic triglyceride accumulation. In essence, their study has delineated a novel regulatory pathway for hepatic de novo lipid synthesis, shedding new light on the molecular underpinnings of NAFLD/NASH progression. These insights not only deepen our understanding of the disease's pathophysiology but also pave the way for innovative therapeutic approaches.

DOI:  10.1016/j.cmet.2024.07.014



02

Cytosolic calcium regulates hepatic mitochondrial oxidation, intrahepatic lipolysis, and gluconeogenesis via CAMKII activation


Traci E. LaMoia,et al.
Cell Metabolism, 2024


Mitochondria, aptly nicknamed the cellular "powerhouses," are pivotal in energy metabolism, harnessing the tricarboxylic acid (TCA) cycle to unlock energy. Emerging research points to a calcium ion dependency within the TCA cycle's dehydrogenase enzymes, with the mitochondrial calcium uniporter (MCU) complex playing a key role by importing calcium ions into the mitochondrial matrix, thus amplifying the mitochondria's oxidative phosphorylation capabilities and energy yield. However, recent insights revealed that calcium fluctuations within the mitochondrial matrix mirror those of the cytoplasm, hinting at a potentially more substantial regulatory role for cytoplasmic calcium in oxidative phosphorylation. Despite this, the underlying mechanisms remain shrouded in mystery, and it is this enigma that the current study seeks to unravel. This investigation unveiled a novel regulatory mechanism in the context of MCU deficiency, where the cytoplasm's accumulated calcium ions steer hepatic lipid metabolism via the CAMKII-ATGL axis, leading to a reduction in hepatic lipid deposition. This discovery not only advanced our comprehension of the intricate interplay between calcium signaling and lipid homeostasis but also casted light on innovative avenues for exploring liver disease pathology. The findings are set to enrich the therapeutic landscape of liver-related disorders by shedding new light on the molecular underpinnings of conditions such as non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH), potentially leading to the development of targeted.

DOI: https://doi.org/10.1016/j.cmet.2024.07.016



相关阅读:
1.Journal Club 20240913

2.Nature Communications | PHD2/3缺陷可增加过继性T细胞治疗效果,增强肿瘤反应(布鲁塞尔鲁汶大学)

END


关注我们获取更多免疫学文献资讯

Editor & Reviewer: Congci Yu


李斌课题组
文献阅读共享
 最新文章